Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,188,875 | -962,472 | -962,763 | -469,229 | -733,339 |
| Depreciation Amortization | 433,100 | 254,820 | 106,482 | 45,090 | 322,466 |
| Accounts receivable | 1,226,098 | 1,172,056 | 137,359 | 548,557 | 419,530 |
| Accounts payable and accrued liabilities | -818,907 | -349,735 | -64,025 | -1,022,948 | 820,665 |
| Other Working Capital | 608,467 | 894,442 | 137,586 | -438,783 | 1,320,811 |
| Other Operating Activity | 256,036 | -837,867 | -74,583 | 514,845 | -1,925,380 |
| Operating Cash Flow | $515,918 | $171,244 | $-719,944 | $-822,468 | $224,752 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -8,236,888 | N/A | N/A | N/A |
| PPE Investments | -193,017 | -126,241 | -85,140 | -50,989 | -308,723 |
| Net Acquisitions | 210,780 | -91,759 | -89,113 | -82,700 | N/A |
| Purchase Of Investment | -12,923,420 | N/A | -4,742,525 | -2,641,862 | -13,385,900 |
| Sale Of Investment | 10,762,100 | 9,427,529 | 6,908,714 | 4,688,707 | 11,621,970 |
| Purchase Sale Intangibles | -649,311 | -672,118 | -649,675 | -599,652 | -179,412 |
| Other Investing Activity | -649,304 | -672,117 | -649,676 | -599,652 | -179,413 |
| Investing Cash Flow | $-2,792,861 | $300,524 | $1,342,260 | $1,313,504 | $-2,252,066 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,580 | N/A | N/A | N/A | N/A |
| Debt Repayment | -20,365 | -10,988 | -9,309 | -4,741 | -2,489 |
| Other Financing Activity | -47,066 | -34,132 | -21,455 | -9,798 | -47,180 |
| Financing Cash Flow | $-59,851 | $-45,120 | $-30,764 | $-14,538 | $-49,668 |
| Exchange Rate Effect | -30,548 | -33,197 | -7,833 | -16,961 | 16,015 |
| Beginning Cash Position | 11,044,610 | 11,410,680 | 11,081,710 | 10,284,160 | 12,621,290 |
| End Cash Position | 8,683,947 | 11,797,590 | 11,657,940 | 10,729,790 | 10,563,350 |
| Net Cash Flow | $-2,360,666 | $386,906 | $576,228 | $445,631 | $-2,057,938 |
| Free Cash Flow | |||||
| Operating Cash Flow | 515,918 | 171,244 | -719,944 | -822,468 | 224,752 |
| Capital Expenditure | -198,108 | -130,800 | -86,275 | -51,516 | -310,022 |
| Free Cash Flow | 317,810 | 40,444 | -806,219 | -873,984 | -85,269 |